Intrathecal immune responses to EBV in early MS

European Journal of Immunology

Volumn 40, Issue 3, 2010, Pages 878-887

  Jaquiéry, Emilie ^a   Jilek, Samantha ^a   Schluep, Myriam ^a   Meylan, Pascal ^a   Lysandropoulos, Andreas ^a   Pantaleo, Giuseppe ^a   Du Pasquier, Renaud A ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

Cellular immune response; Cerebrospinal fluid; EBV; Humoral immune response; MS

Indexed keywords

CYTOMEGALOVIRUS ANTIBODY; EPSTEIN BARR VIRUS ANTIGEN; EPSTEIN BARR VIRUS ANTIGEN 1;

ADULT; AGED; ANTIBODY RESPONSE; ARTICLE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CEREBROSPINAL FLUID; CYTOMEGALOVIRUS INFECTION; CYTOTOXIC T LYMPHOCYTE; DISEASE ASSOCIATION; EPSTEIN BARR VIRUS; HUMAN; HUMAN CELL; HUMAN TISSUE; HUMORAL IMMUNITY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; VIRUS INFECTION;

ADULT; ANTIBODIES, VIRAL; ANTIGENS, VIRAL; CAPSID PROTEINS; CELL SEPARATION; EPSTEIN-BARR VIRUS INFECTIONS; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; FLOW CYTOMETRY; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOGLOBULIN G; MULTIPLE SCLEROSIS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 77749285657     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.200939761     Document Type: Article

References (43)

1. Oksenberg, J. R., Baranzini, S. E., Sawcer, S. and Hauser, S. L., The genetics ofmultiple sclerosis: SNPs to pathways to pathogenesis. Nat. Rev. Genet. 2008. 9: 516-526.
2. Ascherio, A. and Munger, K. L., Environmental risk factors for multiple sclerosis. Part I: the role of infection. Ann. Neurol. 2007. 61: 288-299.
3. Giovannoni, G., Cutter, G. R., Lunemann, J., Martin, R., Munz, C., Sriram, S., Steiner, I. et al., Infectious causes of multiple sclerosis. Lancet Neurol. 2006. 5: 887-894.
4. Haahr, S. and Hollsberg, P., Multiple sclerosis is linked to Epstein-Barr virus infection. Rev. Med. Virol. 2006. 16: 297-310.
5. Ascherio, A., Munger, K. L., Lennette, E. T., Spiegelman, D., Hernan, M. A., Olek, M. J., Hankinson, S. E. et al., Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study. J. Am. Med. Assoc. 2001. 286: 3083-3088.
6. DeLorenze, G. N., Munger, K. L., Lennette, E. T., Orentreich, N., Vogelman, J. H. and Ascherio, A., Epstein-Barr virus and multiple sclerosis: evidence of association from a prospective study with long-term follow-up. Arch. Neurol. 2006. 63: 839-844.
7. Levin, L. I., Munger, K. L., Rubertone, M. V., Peck, C. A., Lennette, E. T., Spiegelman, D. and Ascherio, A., Temporal relationship between elevation of epstein-barr virus antibody titers and initial onset of neurological symptoms in multiple sclerosis. J. Am. Med. Assoc. 2005. 293: 2496-2500.
8. Sundstrom, P., Juto, P.,Wadell, G., Hallmans, G., Svenningsson, A., Nystrom, L., Dillner, J. et al., An altered immune response to Epstein-Barr virus in multiple sclerosis: a prospective study. Neurology 2004. 62: 2277-2282.
9. Cepok, S., Zhou, D., Srivastava, R., Nessler, S., Stei, S., Bussow, K., Sommer, N. et al., Identification of Epstein-Barr virus proteins as putative targets of the immune response in multiple sclerosis. J. Clin. Invest. 2005. 115: 1352-1360.
10. + T cell responses to selected Epstein-Barr virus immunodominant epitopes in patients with multiple sclerosis. Clin. Exp. Immunol. 2003. 132: 137-143.
11. + T-cell response in patients with early multiple sclerosis. Brain 2008. 131: 1712-1721.
12. Lunemann, J. D., Edwards, N., Muraro, P. A., Hayashi, S., Cohen, J. I., Munz, C. and Martin, R., Increased frequency and broadened specificity of latent EBV nuclear antigen-1-specific T cells in multiple sclerosis. Brain 2006. 129: 1493-1506.
13. Bray, P. F., Luka, J., Culp, K. W. and Schlight, J. P., Antibodies against Epstein-Barr nuclear antigen (EBNA) in multiple sclerosis CSF, and two pentapeptide sequence identities between EBNA and myelin basic protein. Neurology 1992. 42: 1798-1804.
14. Sumaya, C. V., Myers, L. W., Ellison, G. W. and Ench, Y., Increased prevalence and titer of Epstein-Barr virus antibodies in patients with multiple sclerosis. Ann. Neurol. 1985. 17: 371-377.
15. Scotet, E., Peyrat,M. A., Saulquin, X., Retiere, C., Couedel, C., Davodeau, F., Dulphy, N. et al., Frequent enrichment for CD8 T cells reactive against common herpes viruses in chronic inflammatory lesions: towards a reassessment of the physiopathological significance of T cell clonal expansions found in autoimmune inflammatory processes. Eur. J. Immunol. 1999. 29: 973-985.
16. Holmoy, T. and Vartdal, F., Cerebrospinal fluid T cells from multiple sclerosis patients recognize autologous Epstein-Barr virus-transformed B cells. J. Neurovirol. 2004. 10: 52-56.
17. Willis, S. N., Stadelmann, C., Rodig, S. J., Caron, T., Gattenloehner, S., Mallozzi, S. S., Roughan, J. E. et al., Epstein-Barr virus infection is not a characteristic feature of multiple sclerosis brain. Brain 2009, 132: 3318-3328.
18. Serafini, B., Rosicarelli, B., Franciotta, D., Magliozzi, R., Reynolds, R., Cinque, P., Andreoni, L. et al., Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain. J. Exp. Med. 2007. 204: 2899-2912.
19. + T cells in multiple sclerosis: a new target for therapy? Brain 2005. 128: 1747-1763.
20. Babbe, H., Roers, A., Waisman, A., Lassmann, H., Goebels, N., Hohlfeld, R., Friese, M. et al., Clonal expansions of CD8(+) T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction. J. Exp. Med. 2000. 192: 393-404.
21. Junker, A., Ivanidze, J., Malotka, J., Eiglmeier, I., Lassmann, H., Wekerle, H., Meinl, E. et al., Multiple sclerosis: T-cell receptor expression in distinct brain regions. Brain 2007. 130: 2789-2799.
22. + T cells in cerebrospinal fluid from multiple sclerosis patients. Brain 2002. 125: 538-550.
23. + T cells in early multiple sclerosis. Clin. Immunol. 2007. 123: 105-113.
24. Buljevac, D., van Doornum, G. J., Flach, H. Z., Groen, J., Osterhaus, A. D., Hop, W., van Doorn, P. A. et al., Epstein-Barr virus and disease activity in multiple sclerosis. J. Neurol. Neurosurg. Psychiatry 2005. 76: 1377-1381.
25. Champagne, P., Ogg, G. S., King, A. S., Knabenhans, C., Ellefsen, K., Nobile, M., Appay, V. et al., Skewed maturation of memory HIV-specific CD8 T lymphocytes. Nature 2001. 410: 106-111.
26. Callahan, M. K., Williams, K. A., Kivisakk, P., Pearce, D., Stins, M. F. and Ransohoff, R. M., CXCR3 marks CD4+ memory T lymphocytes that are competent to migrate across a human brain microvascular endothelial cell layer. J. Neuroimmunol. 2004. 153: 150-157.
27. Reboldi, A., Coisne, C., Baumjohann, D., Benvenuto, F., Bottinelli, D., Lira, S., Uccelli, A. et al., C-C chemokine receptor 6-regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE. Nat. Immunol. 2009. 10: 514-523.
28. Buisson, M., Fleurent, B., Mak, M., Morand, P., Chan, L., Ng, A., Guan, M. et al., Novel immunoblot assay using four recombinant antigens for diagnosis of Epstein-Barr virus primary infection and reactivation. J. Clin. Microbiol. 1999. 37: 2709-2714.
29. Besson, C., Amiel, C., Le-Pendeven, C., Brice, P., Ferme, C., Carde, P., Hermine, O. et al., Positive correlation between Epstein-Barr virus viral load and anti-viral capsid immunoglobulin G titers determined for Hodgkin's lymphoma patients and their relatives. J. Clin. Microbiol. 2006. 44: 47-50.
30. + T cells in multiple sclerosis. J. Immunol. 2006. 176: 7119-7129.
31. Sheehy, M. E., McDermott, A. B., Furlan, S. N., Klenerman, P. and Nixon, D. F., A novel technique for the fluorometric assessment of T lymphocyte antigen specific lysis. J. Immunol. Methods 2001. 249: 99-110.
32. Harari, A., Enders, F. B., Cellerai, C., Bart, P. A. and Pantaleo, G., Distinct profiles of cytotoxic granules in memory CD8 T cells correlate with function, differentiation stage, and antigen exposure. J. Virol. 2009. 83: 2862-2871.
33. Galea, I., Bernardes-Silva, M., Forse, P. A., van Rooijen, N., Liblau, R. S. and Perry, V. H., An antigen-specific pathway for CD8 T cells across the blood-brain barrier. J. Exp. Med. 2007. 204: 2023-2030.
34. Yajima, M., Imadome, K., Nakagawa, A., Watanabe, S., Terashima, K., Nakamura, H., Ito, M. et al., A new humanized mouse model of Epstein-Barr virus infection that reproduces persistent infection, lymphoproliferative disorder, and cell-mediated and humoral immune responses. J. Infect. Dis. 2008. 198: 673-682.
35. Donelan, N., Dinzey, J., Lin, J., Brydon, E. W. and Sadiq, S. A., Cerebrospinal fluid screening for evidence of Epstein Barr virus presence in multiple sclerosis. Mult. Scler. 2008. 14: S120.
36. Alvarez-Lafuente, R., Garcia-Montojo, M., De Las Heras, V., Dominguez-Mozo, M. I., Bartolome, M., Benito-Martin, M. S. and Arroyo, R., Herpesviruses and human endogenous retroviral sequences in the cerebrospinal fluid of multiple sclerosis patients. Mult. Scler. 2008. 14: 595-601.
37. Kuenz, B., Lutterotti, A., Ehling, R., Gneiss, C., Haemmerle, M., Rainer, C., Deisenhammer, F. et al., Cerebrospinal fluid B cells correlate with early brain inflammation in multiple sclerosis. PLoS One 2008. 3: e2559.
38. Lau, L. L., Jamieson, B. D., Somasundaram, T. and Ahmed, R., Cytotoxic T-cell memory without antigen. Nature 1994. 369: 648-652.
39. Polman, C. H., Reingold, S. C., Edan, G., Filippi, M.,Hartung,H. P., Kappos, L., Lublin, F. D. et al., Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann. Neurol. 2005. 58: 840-846.
40. Reiber, H. and Lange, P., Quantification of virus-specific antibodies in cerebrospinal fluid and serum: sensitive and specific detection of antibody synthesis in brain. Clin. Chem. 1991. 37: 1153-1160.
41. Du Pasquier, R. A., Autissier, P., Zheng, Y., Jean-Jacques, J. and Koralnik, I. J., Presence of JC virus-specific CTL in the cerebrospinal fluid of PML patients: rationale for immune-based therapeutic strategies. AIDS 2005. 19: 2069-2076.
42. Horton, H., Russell,N., Moore, E., Frank, I., Baydo, R.,Havenar-Daughton, C., Lee, D. et al., Correlation between interferon- gamma secretion and cytotoxicity, in virus-specific memory T cells. J. Infect. Dis. 2004. 190: 1692-1696.
43. Annels, N. E., Callan, M. F., Tan, L. and Rickinson, A. B., Changing patterns of dominant TCR usage with maturation of an EBV-specific cytotoxic T cell response. J. Immunol. 2000. 165: 4831-4841.